Cargando…
Cellular responses to ionising radiation of AT heterozygotes: differences between missense and truncating mutation carriers
It has been estimated that approximately 1% of the general population are ataxia telangiectasia (AT) mutated (ATM) heterozygotes. The ATM protein plays a central role in DNA-damage response pathways; however, the functional consequences of the presence of either heterozygous truncating or missense m...
Autores principales: | Fernet, M, Moullan, N, Lauge, A, Stoppa-Lyonnet, D, Hall, J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2410162/ https://www.ncbi.nlm.nih.gov/pubmed/14970866 http://dx.doi.org/10.1038/sj.bjc.6601549 |
Ejemplares similares
-
Breast cancer risk in ataxia telangiectasia (AT) heterozygotes: haplotype study in French AT families
por: Janin, N, et al.
Publicado: (1999) -
A recurrent truncating germline mutation in the BRIP1/FANCJ gene and susceptibility to prostate cancer
por: Kote-Jarai, Z, et al.
Publicado: (2009) -
Germline truncating mutations in both MSH2 and BRCA2 in a single kindred
por: Thiffault, I, et al.
Publicado: (2004) -
Truncating mutations of PPM1D are found in blood DNA samples of lung cancer patients
por: Zajkowicz, A, et al.
Publicado: (2015) -
Missense mutations in CRX homeodomain cause dominant retinopathies through two distinct mechanisms
por: Zheng, Yiqiao, et al.
Publicado: (2023)